Abstract |
The fusion gene AML1-ETO initially dysregulates various cell cycle molecules in t(8;21) acute myeloid leukemia. Aurora kinases have shown great promise in treating tumors. However, the efficacy of Aurora kinase (AURK) A and B inhibition in t(8;21) AML remains unclear. We found that AURK-A inhibitor Alisertib and AURK-B inhibitor Barasertib strongly inhibited the growth and proliferation of t(8;21) AML cells. The quantity and size of cell colonies were markedly decreased after a 14-d drug exposure. The cell cycle distribution was blocked at the G2/M phase in both dose- and time-dependent manner. The expression of p53 family and cdc2-p34 significantly changed as well. Notably, we found that t(8;21) AML cells are more sensitive to Aurora B inhibition. In each set of experiments, Barasertib took less time or a lower concentration to achieve similar efficacy. Taken together, our data highlighted the potential role of Aurora kinases as promising cell cycle targets for the treatment of t(8;21) AML and hereby provided a theoretical basis to guide relevant clinical trials.
|
Authors | Jialei Qi, Xiang Gao, Xiaomin Zhong, Ninghan Zhang, Rong Wang, Huihui Zhang, Ting Pan, Xuejiao Liu, Yao Yao, Qingyun Wu, Mingshan Niu, Kailin Xu |
Journal | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
(Biomed Pharmacother)
Vol. 117
Pg. 109113
(Sep 2019)
ISSN: 1950-6007 [Electronic] France |
PMID | 31207577
(Publication Type: Journal Article)
|
Copyright | Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved. |
Chemical References |
- 2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate
- Azepines
- Cell Cycle Proteins
- MLN 8237
- Organophosphates
- Protein Kinase Inhibitors
- Pyrimidines
- Quinazolines
- Aurora Kinase A
- Aurora Kinase B
|
Topics |
- Aurora Kinase A
(antagonists & inhibitors, metabolism)
- Aurora Kinase B
(antagonists & inhibitors, metabolism)
- Azepines
(pharmacology)
- Cell Cycle Checkpoints
(drug effects)
- Cell Cycle Proteins
(metabolism)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Chromosomes, Human, Pair 21
(genetics)
- Chromosomes, Human, Pair 8
(genetics)
- Humans
- Leukemia, Myeloid, Acute
(genetics, pathology)
- Organophosphates
(pharmacology)
- Protein Kinase Inhibitors
(pharmacology)
- Pyrimidines
(pharmacology)
- Quinazolines
(pharmacology)
- Time Factors
- Translocation, Genetic
- Tumor Stem Cell Assay
|